From: Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
 | Losartan (n = 20) | Telmisartan (n = 20) | P value |
---|---|---|---|
Mean ± SD age (years) | 56.2 ± 11.0 | 55.3 ± 12.4 | NS |
Males/females | 11/9 | 12/8 | Â |
Office blood pressure (mmHg) | Â | Â | Â |
   Mean ± SD SBP | 149.7 ± 9.0 | 151.3 ± 7.1 |  |
   Mean ± SD DBP | 91.2 ± 7.4 | 89.8 ± 8.7 |  |
24-hour mean blood pressure (mmHg) | Â | Â | Â |
   Mean ± SD SBP | 142.8 ± 12.0 | 143.6 ± 14.0 | NS |
   Mean ± SD DBP | 88.8 ± 10.2 | 88.3 ± 9.5 | NS |
Mean ± SD body mass index (kg/m2) | 32.1 ± 7.2 | 34.5 ± 6.3 | NS |
Impaired glucose tolerance (n) | 19 | 17 | NS |
Type 2 diabetics (n) | 1 | 3 | NS |
Metabolic syndrome components (n)a | Â | Â | Â |
   3 | 11 | 10 | NS |
   4 | 7 | 8 | NS |
   5 | 2 | 2 | NS |
Total cholesterol (mg/dl) | 212.6 ± 45.8 | 209.6 ± 50.8 | NS |
Low-density lipoprotein cholesterol (mg/dl) | 134 ± 44 | 138 ± 34 | NS |
High-density lipoprotein cholesterol (mg/dl) | 51.2 ± 11 | 56.3 ± 17 | NS |
Triglycerides (mg/dl) | 221 ± 32 | 210 ± 23 | NS |